ADAG
Adagene Inc - ADR

225
Mkt Cap
$140.45M
Volume
58,162.00
52W High
$3.19
52W Low
$1.30
PE Ratio
-4.62
ADAG Fundamentals
Price
$3.10
Prev Close
$2.98
Open
$2.96
50D MA
$2.07
Beta
0.08
Avg. Volume
212,980.75
EPS (Annual)
-$0.7426
P/B
3.70
Rev/Employee
$748.23
$22.91
Loading...
Loading...
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
138

Frequently Asked Questions

What is Market Cap of Adagene Inc - ADR?
What is the 52-week high for Adagene Inc - ADR?
What is the 52-week low for Adagene Inc - ADR?
What is Adagene Inc - ADR stock price today?
What was Adagene Inc - ADR stock price yesterday?
What is the PE ratio of Adagene Inc - ADR?
What is the Price-to-Book ratio of Adagene Inc - ADR?
What is the 50-day moving average of Adagene Inc - ADR?
How many employees does Adagene Inc - ADR have?

Latest ADAG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.